Technical Analysis for ARPO - Aerpio Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 0.51 4.72% 0.02
ARPO closed up 4.72 percent on Thursday, November 14, 2019, on 2.11 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical ARPO trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Fell Below 20 DMA Bearish 4.72%
180 Bearish Setup Bearish Swing Setup -4.69%
20 DMA Support Bullish -7.27%
20 DMA Support Bullish -5.56%
Doji - Bullish? Reversal -5.56%
Narrow Range Bar Range Contraction -5.56%
Inside Day Range Contraction -5.56%

Older signals for ARPO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aerpio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for ocular diseases. The company's lead product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a single ascending dose clinical trial for the treatment of inflammatory bowel disease. The company is headquartered in Cincinnati, Ohio. Aerpio Pharmaceuticals, Inc. operates independently of Akebia Therapeutics, Inc. as of December 22, 2011.
Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Pharmacy Monoclonal Antibodies Inflammatory Bowel Disease Diabetic Retinopathy Treatment Of Inflammatory Bowel Disease Hypoxia Inducible Factors Retinopathy
Is ARPO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.25
52 Week Low 0.45
Average Volume 102,613
200-Day Moving Average 1.2011
50-Day Moving Average 0.601
20-Day Moving Average 0.5268
10-Day Moving Average 0.5375
Average True Range 0.0402
ADX 38.18
+DI 8.2095
-DI 26.097
Chandelier Exit (Long, 3 ATRs ) 0.4493
Chandelier Exit (Short, 3 ATRs ) 0.5806
Upper Bollinger Band 0.5739
Lower Bollinger Band 0.4797
Percent B (%b) 0.32
BandWidth 17.881549
MACD Line -0.0184
MACD Signal Line -0.021
MACD Histogram 0.0025
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.54
Resistance 3 (R3) 0.54 0.53 0.54
Resistance 2 (R2) 0.53 0.52 0.53 0.53
Resistance 1 (R1) 0.52 0.52 0.53 0.52 0.53
Pivot Point 0.51 0.51 0.51 0.51 0.51
Support 1 (S1) 0.50 0.50 0.51 0.50 0.49
Support 2 (S2) 0.49 0.50 0.49 0.49
Support 3 (S3) 0.48 0.49 0.49
Support 4 (S4) 0.48